Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹3,328 Cr₹1,609 Cr₹3,877 Cr₹3,593 Cr₹3,159 Cr

What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹3,328 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹3,328 Cr
Mar2024₹1,609 Cr
Mar2023₹3,877 Cr
Mar2022₹3,593 Cr
Mar2021₹3,159 Cr

How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2025 ₹3,328 Cr
106.80
Mar2024 ₹1,609 Cr
-58.49
Mar2023 ₹3,877 Cr
7.92
Mar2022 ₹3,593 Cr
13.75
Mar2021 ₹3,159 Cr -

Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,008.6 Cr 1.2% 4% 43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹108,360.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 1% 10.8% 4.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.2%

4%

43.9%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses